Musculoskeletal Rehabilitation in the Person with Scleroderma

Janet L. Poole


Curr Opin Rheumatol. 2010;22(2):205 

In This Article


Conclusions must be interpreted with caution because of the limited number of studies, small sample sizes, and lack of well designed studies. The rarity of scleroderma makes it a challenging disease to study and this makes it imperative to design multicenter trials to increase the number of participants and develop specific protocols.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: